EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients

Ramin Ravangard iD, Khosro Keshavarz, Mozhgan Seif, Shahryar Zeighami, Abdosaleh Jafari, Faride Sadat Jalali iD

Prostate Cancer · 2026-01 · 2026 (1)

DOI: 10.1155/proc/2149782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate Cancer, online erschienen am 15.04.2026. Verfasst von Ramin Ravangard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran, su…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) ranks as the fourth most prevalent form of cancer overall and imposes a substantial financial burden on individuals and communities. Given information on the costs of this disease and the factors influencing them, the present study analyzed factors affecting the costs of medical and nonmedical services for patients with PCa in southern Iran.

Methods

Factors affecting the cost of PCa were identified through a scoping review of international databases (ISI Web of Science, Scopus, PubMed, ProQuest, Magiran, and SID) and consultation with PCa experts. Subsequently, data on 254 PCa patients were collected between March 2020 and March 2022 using a two‐stage stratified random sampling method. Patients were randomly selected from the provincial Cancer Registry Center lists within strata defined by healthcare catchment areas. Multiple regression analysis using SPSS 13.0 was employed to determine the factors influencing costs.

Results

The findings from the multiple regression analysis indicated that premature mortality, grade, and monthly income (all p value < 0.001) were important factors affecting PCa patients’ costs.

Conclusions

In line with the results, implementing low‐cost screening systems for early detection and effective treatment of PCa at all income levels, and directing targeted subsidies to the health sector, especially to low‐income patients, can help reduce costs for PCa patients.

Schlagwörter

Stichwörter der Autor:innen

Irancost drivercost of illnessprostate neoplasm

Autor:innen und Institutionen

  • Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Non-Communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.

ORCID-Profile: Ramin Ravangard, Faride Sadat Jalali

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Ravangard, R., Keshavarz, K., Seif, M., Zeighami, S., Jafari, A., & Jalali, F. S. (2026). Determinants of the Cost of Illness in Iranian Prostate Cancer Patients. Prostate Cancer, 2026(1). https://doi.org/10.1155/proc/2149782

Vancouver

Ravangard R, Keshavarz K, Seif M, Zeighami S, Jafari A, Jalali FS. Determinants of the Cost of Illness in Iranian Prostate Cancer Patients. Prostate Cancer. 2026;2026(1). doi:10.1155/proc/2149782

BibTeX
@article{Ravangard2026,
  author = {Ravangard, Ramin and Keshavarz, Khosro and Seif, Mozhgan and Zeighami, Shahryar and Jafari, Abdosaleh and Jalali, Faride Sadat},
  title = {Determinants of the Cost of Illness in Iranian Prostate Cancer Patients},
  journal = {Prostate Cancer},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/proc/2149782}
}
Kostenlos starten →